All In Biotech

Free tool

FAERS Monitor: Technetium Tc-99m Medronate Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018107 or its brand name (Technetium Tc-99m Medronate Kit, Technetium Tc-99m Medronate Kit). Reports on generic versions are filed under their own applications.

Reports

5

Serious

2

40% of reports

Hospitalization

1

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pruritus2
  • chills1
  • dysphagia1
  • erythema1
  • eye oedema1
  • eye pain1
  • hypersensitivity1
  • hypoaesthesia1
  • mucosal inflammation1
  • palpitations1
  • rash1
  • stomatitis1
  • throat tightness1
  • visual impairment1
  • vomiting1

Reports by year received

View as table
YearReports
20131
20141
20153

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,154 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eye oedema11715.9297.1428
mucosal inflammation1160.727.839
throat tightness1155.526.938
eye pain174.612.918
stomatitis169.412.016
dysphagia144.37.710
palpitations135.96.28
chills135.96.28
visual impairment133.95.98
hypoaesthesia128.14.96
hypersensitivity122.73.95
pruritus221.97.522
erythema120.53.54
rash19.71.72
vomiting18.91.51

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.